|
The best way you can protect yourself from lung cancer is to be aware of what makes a person more likely to get it. These are called your risk factors. Knowing what puts you at risk for lung cancer can help you make healthy choices in your life to help you avoid it.
|
|
Cigarette smoking causes 87 percent of lung cancer deaths and is responsible for most cancers of the larynx, oral cavity, esophagus, and bladder (see Question 1).
|
|
1. How important is it to stop smoking? It is very important. Tobacco use remains the single most preventable cause of death in the United States. Cigarette smoking accounts for nearly one-third of all cancer deaths in this country each year.
|
|
Key Points The lower tar and nicotine numbers on light cigarette packs and in ads are misleading (see Question 1).
|
|
Learn how to get help to quit smoking and improve your chances of quitting. This document explains the best ways for you to quit as well as new treatments to help. It lists new medications that can double or triple your chances of quitting and quitting for good. It also tells about ways to avoid relapses and talks about concerns you may have about quitting, including weight gain.
|
|
When you've been diagnosed with cancer--particularly lung cancer--it may be hard to think or talk about quitting smoking. Why? Because you smoke even though everybody knows that smoking is bad for your health. And everyone knows that it can cause cancer. Plus, we also know that quitting is hard.
|
|
Key Points Secondhand smoke (also called environmental tobacco smoke) is the combination of smoke given off by the burning end of a tobacco product and the smoke exhaled by the smoker (see Question 1).
|
|
Key Points Snuff is a finely ground or shredded tobacco that is either sniffed through the nose or placed between the cheek and gum. Chewing tobacco is used by putting a wad of tobacco inside the cheek (see Question 1).
|
|
|
Lung cancer is difficult to find in its early stages. To date, there is no standard screening process to find early stage lung cancer. Current available detection tests—chest x-rays and sputum tests—are not always accurate in finding early lung cancer.
|
|
What is NLST? The National Lung Screening Trial (NLST) is a lung cancer screening trial sponsored by the National Cancer Institute (NCI). Screening means testing people to detect a disease before it causes symptoms.
|
|
The National Cancer Institute (NCI), part of the National Institutes of Health, in partnership with the American Cancer Society, has enrolled its goal of 50,000 current or former smokers in the National Lung Screening Trial (NLST). The study, launched in September 2002, was designed to determine if screening with either spiral computed tomography (CT) or chest X-ray before the appearance of symptoms can reduce deaths from lung cancer. Although the trial has reached its 50,000 participant goal, it remains open at select sites to collect blood, urine and phlegm to help doctors identify biomarkers, or tumor markers, of lung cancer.
|
|
|
The lack of effective methods for early detection of lung cancer is one of the reasons that most people diagnosed with lung cancer have advanced disease, and fewer than fifteen percent of these patients will survive more than five years.
|
|
|
You may not notice signs of lung cancer in its early stages. In fact, many lung cancers are found through a chest X-ray taken for other reasons.
|